YU68602A - Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje - Google Patents
Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenjeInfo
- Publication number
- YU68602A YU68602A YU68602A YUP68602A YU68602A YU 68602 A YU68602 A YU 68602A YU 68602 A YU68602 A YU 68602A YU P68602 A YUP68602 A YU P68602A YU 68602 A YU68602 A YU 68602A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- monoclonal antibodies
- production
- ldl receptor
- human ldl
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/82—Hepatitis associated antigens and antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Ovde su data monoklonska antitela na LDL receptor koja su korisna za identifikaciju i prečišćavanje LDL kao i u lečenju, na primer infekcije virusom hepatitis C.[There are provided monoclonal antibodies to the human LDL receptor which are useful for the identification and purification of LDL and in treatment of e.g. hepatitis C infection.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL13502500A IL135025A0 (en) | 2000-03-13 | 2000-03-13 | Monoclonal antibodies to the human ldl receptor, their production and use |
IL13921700A IL139217A0 (en) | 2000-03-13 | 2000-10-23 | Monoclonal antibodies to the human ldl receptor, their production and use |
PCT/IL2001/000216 WO2001068710A1 (en) | 2000-03-13 | 2001-03-08 | Monoclonal antibodies to the human ldl receptor, their production and use |
Publications (2)
Publication Number | Publication Date |
---|---|
YU68602A true YU68602A (sh) | 2006-03-03 |
RS51406B RS51406B (sr) | 2011-02-28 |
Family
ID=26323933
Country Status (33)
Country | Link |
---|---|
US (1) | US6849720B2 (sh) |
EP (1) | EP1263790B1 (sh) |
JP (1) | JP4768193B2 (sh) |
KR (1) | KR100882081B1 (sh) |
CN (1) | CN1418225B (sh) |
AR (1) | AR028518A1 (sh) |
AT (1) | ATE362490T1 (sh) |
AU (2) | AU2001241002B8 (sh) |
BG (1) | BG65762B1 (sh) |
BR (1) | BR0109164A (sh) |
CA (1) | CA2402593C (sh) |
CY (1) | CY1108020T1 (sh) |
CZ (1) | CZ20023098A3 (sh) |
DE (1) | DE60128452T2 (sh) |
DK (1) | DK1263790T3 (sh) |
EA (1) | EA007494B1 (sh) |
EE (1) | EE200200517A (sh) |
ES (1) | ES2282238T3 (sh) |
HK (1) | HK1055750A1 (sh) |
HR (1) | HRP20020704B1 (sh) |
HU (1) | HU226194B1 (sh) |
IL (2) | IL139217A0 (sh) |
MX (1) | MXPA02009091A (sh) |
NO (1) | NO330904B1 (sh) |
NZ (1) | NZ520944A (sh) |
PL (1) | PL206041B1 (sh) |
PT (1) | PT1263790E (sh) |
RS (1) | RS51406B (sh) |
SI (1) | SI1263790T1 (sh) |
SK (1) | SK287348B6 (sh) |
UA (1) | UA78489C2 (sh) |
WO (1) | WO2001068710A1 (sh) |
ZA (1) | ZA200206654B (sh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0114629D0 (en) * | 2001-06-15 | 2001-08-08 | Pfizer Ltd | Method |
WO2004111652A1 (en) | 2003-06-19 | 2004-12-23 | Applied Research Systems Ars Holding N.V. | Use of prion conversion modulating agents |
FR2889532B1 (fr) * | 2005-08-03 | 2007-10-12 | Lab Francais Du Fractionnement | Anticorps diriges contre le recepteur du ldl |
FR2889533B1 (fr) * | 2005-08-03 | 2007-10-12 | Lab Francais Du Fractionnement | Anticorps diriges contre le recepteur du ldl |
EP1991869A2 (en) * | 2006-02-17 | 2008-11-19 | Paolo La Colla | Methods for the diagnosis of proliferative and/or conformational diseases |
FR2910896B1 (fr) * | 2006-12-29 | 2012-11-16 | Lab Francais Du Fractionnement | Anticorps monoclonal dirige contre le recepteur humain des ldl |
IL182956A0 (en) | 2007-05-03 | 2008-01-20 | Yeda Res & Dev | Glycan modified soluble receptors and binding proteins and their use |
IL188628A0 (en) * | 2008-01-07 | 2008-12-29 | Yeda Res & Dev | Use of soluble ldl-r for viral hepatitis |
GB0922377D0 (en) * | 2009-12-22 | 2010-02-03 | Arab Gulf University The | Mutant LDL receptor |
US20130129676A1 (en) | 2010-05-25 | 2013-05-23 | Universite De Strasbourg | Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection |
WO2013024157A2 (en) | 2011-08-17 | 2013-02-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Combinations of host targeting agents for the treatment and the prevention of hcv infection |
WO2013024155A1 (en) | 2011-08-17 | 2013-02-21 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Combinations of anti-hcv-entry factor antibodies and direct acting antivirals for the treatment and the prevention of hcv infection |
WO2013024156A2 (en) | 2011-08-17 | 2013-02-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection |
CN103111270B (zh) * | 2013-02-26 | 2015-06-10 | 王业富 | 一种乙型肝炎抗原蛋白的吸附材料及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5182364A (en) * | 1990-02-26 | 1993-01-26 | The Scripps Research Institute | Polypeptide analogs of apolipoprotein E |
US5496926A (en) * | 1992-01-19 | 1996-03-05 | Yeda Research And Development Co. Ltd. | Process of preparing a soluble LDL receptor |
US5945308A (en) * | 1998-04-03 | 1999-08-31 | Incyte Pharmaceuticals, Inc. | Human oxidized LDL receptor |
JP2000279174A (ja) * | 1999-03-30 | 2000-10-10 | Bml Inc | ヒトldlレセプターに対するモノクローナル抗体及びこれを用いる家族性高脂血症の判定方法 |
-
2000
- 2000-10-23 IL IL13921700A patent/IL139217A0/xx unknown
-
2001
- 2001-03-08 JP JP2001567800A patent/JP4768193B2/ja not_active Expired - Fee Related
- 2001-03-08 MX MXPA02009091A patent/MXPA02009091A/es active IP Right Grant
- 2001-03-08 RS YUP-686/02A patent/RS51406B/sr unknown
- 2001-03-08 NZ NZ520944A patent/NZ520944A/en not_active IP Right Cessation
- 2001-03-08 US US10/221,679 patent/US6849720B2/en not_active Expired - Fee Related
- 2001-03-08 EP EP01912086A patent/EP1263790B1/en not_active Expired - Lifetime
- 2001-03-08 AT AT01912086T patent/ATE362490T1/de active
- 2001-03-08 IL IL15171301A patent/IL151713A0/xx not_active IP Right Cessation
- 2001-03-08 EE EEP200200517A patent/EE200200517A/xx unknown
- 2001-03-08 SI SI200130736T patent/SI1263790T1/sl unknown
- 2001-03-08 CZ CZ20023098A patent/CZ20023098A3/cs unknown
- 2001-03-08 KR KR1020027011767A patent/KR100882081B1/ko not_active IP Right Cessation
- 2001-03-08 DK DK01912086T patent/DK1263790T3/da active
- 2001-03-08 HU HU0300142A patent/HU226194B1/hu not_active IP Right Cessation
- 2001-03-08 AU AU2001241002A patent/AU2001241002B8/en not_active Ceased
- 2001-03-08 CA CA2402593A patent/CA2402593C/en not_active Expired - Fee Related
- 2001-03-08 SK SK1312-2002A patent/SK287348B6/sk not_active IP Right Cessation
- 2001-03-08 DE DE60128452T patent/DE60128452T2/de not_active Expired - Lifetime
- 2001-03-08 ES ES01912086T patent/ES2282238T3/es not_active Expired - Lifetime
- 2001-03-08 PL PL358381A patent/PL206041B1/pl unknown
- 2001-03-08 EA EA200200974A patent/EA007494B1/ru not_active IP Right Cessation
- 2001-03-08 BR BR0109164-6A patent/BR0109164A/pt not_active Application Discontinuation
- 2001-03-08 AU AU4100201A patent/AU4100201A/xx active Pending
- 2001-03-08 WO PCT/IL2001/000216 patent/WO2001068710A1/en active IP Right Grant
- 2001-03-08 PT PT01912086T patent/PT1263790E/pt unknown
- 2001-03-08 CN CN018065740A patent/CN1418225B/zh not_active Expired - Fee Related
- 2001-03-12 AR ARP010101148A patent/AR028518A1/es active IP Right Grant
- 2001-08-03 UA UA2002108101A patent/UA78489C2/uk unknown
-
2002
- 2002-08-20 ZA ZA200206654A patent/ZA200206654B/en unknown
- 2002-08-28 HR HR20020704A patent/HRP20020704B1/xx not_active IP Right Cessation
- 2002-09-04 NO NO20024223A patent/NO330904B1/no not_active IP Right Cessation
- 2002-09-05 BG BG107063A patent/BG65762B1/bg unknown
-
2003
- 2003-11-11 HK HK03108147.2A patent/HK1055750A1/xx not_active IP Right Cessation
-
2007
- 2007-07-13 CY CY20071100939T patent/CY1108020T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR12C0004I2 (fr) | Anticorps contre l'antigene ctla-4 humain et utilisation | |
IL172854A0 (en) | Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations | |
EP1194164B8 (en) | Prion protein peptides and uses thereof | |
DE60023043T2 (de) | (S,S)-Reboxetin zur Behandlung von Inkontinenz | |
MXPA03001590A (es) | Anticuerpos para la il-1beta humana. | |
AU2001235006A1 (en) | Prophylactic and therapeutic monoclonal antibodies | |
PT1157042E (pt) | Produção de anticorpos tetravalentes | |
DE60137631D1 (de) | Ireovirus antikörpern zur behandlung von ras-vermittelten, proliferativen erkrankungen | |
YU68602A (sh) | Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje | |
MXPA04005079A (es) | Variantes del dominio c2 del factor viii. | |
DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
AU2001233912A1 (en) | Diagnosis of breast cancer using bcmp-81 as marker | |
MXPA04001986A (es) | Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad. | |
EP1370697A4 (en) | PEROXYREDOXIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV-1 INFECTIONS AND METHODS OF USE | |
DE60005526D1 (de) | Verwendung von 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine zur behandlung von erkrankungen des magen-darm-traktes | |
IL135025A0 (en) | Monoclonal antibodies to the human ldl receptor, their production and use | |
DK1299350T3 (da) | Substituerede benzamider til styrket immunforsvar og behandling af kræft, infektioner og manio-depressive sygdomme |